| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 79.27B | 100.61B | 59.97B | 42.57B | 33.72B | 24.79B |
| Gross Profit | 42.06B | 53.29B | 31.66B | 24.49B | 19.86B | 14.49B |
| EBITDA | 8.30B | 10.96B | 5.79B | 3.83B | 4.26B | 2.58B |
| Net Income | 3.99B | 5.27B | 2.41B | 1.45B | 2.27B | 1.31B |
Balance Sheet | ||||||
| Total Assets | 52.06B | 54.72B | 46.58B | 21.49B | 17.80B | 10.29B |
| Cash, Cash Equivalents and Short-Term Investments | 19.02B | 19.98B | 13.22B | 7.76B | 7.01B | 4.77B |
| Total Debt | 25.50B | 23.99B | 26.92B | 8.07B | 5.05B | 3.12B |
| Total Liabilities | 33.32B | 33.29B | 34.09B | 12.88B | 9.56B | 5.69B |
| Stockholders Equity | 18.74B | 21.43B | 12.49B | 8.61B | 8.24B | 4.59B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 7.11B | 1.76B | 685.64M | 2.71B | 1.92B |
| Operating Cash Flow | 0.00 | 7.52B | 2.13B | 1.24B | 2.97B | 2.08B |
| Investing Cash Flow | 0.00 | -1.13B | -14.44B | -1.61B | -2.35B | -449.67M |
| Financing Cash Flow | 0.00 | 394.66M | 17.82B | 1.05B | 1.59B | -478.68M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥27.91B | 8.12 | ― | 3.77% | 7.88% | -5.92% | |
65 Neutral | ¥189.29B | 27.65 | ― | 0.64% | 57.01% | 91.03% | |
65 Neutral | ¥40.45B | 9.40 | ― | 2.19% | 17.90% | 14.14% | |
64 Neutral | ¥31.23B | 11.19 | ― | 1.73% | ― | ― | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
60 Neutral | ¥67.43B | 4.34 | ― | 1.81% | 6.48% | -38.41% | |
59 Neutral | ¥25.11B | 3.19 | ― | 0.95% | 4.14% | ― |